|
|
|
|
LEADER |
00000cam a2200000 i 4500 |
001 |
EBOOKCENTRAL_ocn961453589 |
003 |
OCoLC |
005 |
20240329122006.0 |
006 |
m o d |
007 |
cr cnu---unuuu |
008 |
161029s2016 sz ob 001 0 eng d |
040 |
|
|
|a EBLCP
|b eng
|e pn
|c EBLCP
|d YDX
|d AZU
|d OCLCO
|d GW5XE
|d IAV
|d IDEBK
|d STF
|d UPM
|d COO
|d OCLCF
|d IOG
|d OTZ
|d N$T
|d CASUM
|d VT2
|d IAD
|d JBG
|d ICW
|d ILO
|d ICN
|d OCLCQ
|d ESU
|d OCLCQ
|d OCLCO
|d OCLCA
|d U3W
|d OCLCO
|d OCLCA
|d REB
|d CAUOI
|d KSU
|d AU@
|d OCLCO
|d OCLCQ
|d WYU
|d OCLCA
|d OCLCQ
|d OCLCO
|d ERF
|d ADU
|d LEATE
|d UKAHL
|d OCLCQ
|d OCLCA
|d OCLCQ
|d NLW
|d OCLCO
|d OCLCQ
|d OCL
|d DCT
|d OCLCO
|d OCLCL
|d OCLCQ
|
019 |
|
|
|a 961414804
|a 961828599
|a 964806786
|a 967615694
|a 981107570
|a 985057616
|a 1005816654
|a 1012078982
|a 1026464540
|a 1048167690
|a 1058942319
|a 1066475939
|a 1086524065
|a 1112595968
|a 1113462653
|a 1116171796
|a 1122819170
|a 1127200846
|a 1136372761
|a 1204059369
|
020 |
|
|
|a 9783319429823
|q (electronic bk.)
|
020 |
|
|
|a 3319429825
|q (electronic bk.)
|
020 |
|
|
|z 9783319429809
|
020 |
|
|
|z 3319429809
|
024 |
7 |
|
|a 10.1007/978-3-319-42982-3
|2 doi
|
029 |
1 |
|
|a AU@
|b 000058910103
|
035 |
|
|
|a (OCoLC)961453589
|z (OCoLC)961414804
|z (OCoLC)961828599
|z (OCoLC)964806786
|z (OCoLC)967615694
|z (OCoLC)981107570
|z (OCoLC)985057616
|z (OCoLC)1005816654
|z (OCoLC)1012078982
|z (OCoLC)1026464540
|z (OCoLC)1048167690
|z (OCoLC)1058942319
|z (OCoLC)1066475939
|z (OCoLC)1086524065
|z (OCoLC)1112595968
|z (OCoLC)1113462653
|z (OCoLC)1116171796
|z (OCoLC)1122819170
|z (OCoLC)1127200846
|z (OCoLC)1136372761
|z (OCoLC)1204059369
|
037 |
|
|
|n Title purchased via APUC SHEDL / ScopNet ebook agreement
|n Medicine (Springer-11650)
|
050 |
|
4 |
|a RC681
|
072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
072 |
|
7 |
|a MJD
|2 bicssc
|
082 |
0 |
4 |
|a 616.1/2
|2 23
|
049 |
|
|
|a UAMI
|
245 |
0 |
0 |
|a Cardiac biomarkers :
|b case studies and clinical correlations /
|c Alan S. Maisel, Allan S. Jaffe, editors.
|
264 |
|
1 |
|a [Cham] :
|b Springer,
|c 2016.
|
300 |
|
|
|a 1 online resource (368 pages)
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
347 |
|
|
|a text file
|b PDF
|2 rda
|
588 |
0 |
|
|a Online resource; title from PDF title page (EBSCO, viewed April 3, 2017).
|
504 |
|
|
|a Includes bibliographical references and index.
|
505 |
0 |
|
|a Part I. Ischemic Heart Disease -- 1. Pre-analytical factors and analytical issues affecting interpretation of cardiovascular biomarkers -- 2. Troponin basics for clinicians -- 3. Unique aspects of high sensitivity assays: what are they, why do we need them, and how do we use them? -- 4. Evaluation of patients presenting with chest pain in the emergency department: where do troponins fit in? -- 5. Using cardiac troponins in patients with acute myocardial infarction -- 6. What is a Type 2 myocardial infaction: how is it recognized and what should one do to establish that diagnosis? -- 7. Use of cardiac troponin in patients with heart failure -- 8. Elevated cTn in other acute situations such as atrial fibrillation, sepsis, respiratory failure, and gastrointestinal bleeding -- 9. Use of cTn for detection of more chronic disease states -- 10. Use of high-sensitive cTn assays for the evaluation of patients potentially at risk for cardiovascular disease -- 11. Other biomarkers in acute coronary syndrome -- 12. Newer lipid markers: apolipoprotein B, LDL particle concentration, and triglyceride-rich lipoproteins, when are they needed? -- Part II. Heart Failure -- 12. Natriuretic peptides: physiology for the clinician -- 14. Natriuretic peptides: basic analytic considerations -- 15. Natriuretic peptide use in screening in the community -- 16. Natriuretic peptide use in the emergency department -- 17. Heart failure: natriuretic peptide use in the hospital -- 18. Natriuretic peptide guided therapy in outpatient heart failure management -- 19. Caveats using natriuretic peptide levels -- 20. Gaps in our biomarker armamentarium: what novel biomarkers might be synergistic in patients with acute disease -- 21. Biomarkers in heart failure: ST2 -- 22. Biomarkers in heart failure: procalcitonin -- 23. Novel biomarkers in heart failure: adrenomedullin and proenkephalin -- 24. Biomarkers in specific disease states: cardio-oncology -- 25. Biomarkers of sarcopenia and mitochondrial dysfunction -- 26. Biomarkers in arrhythmias, sudden death, and device therapy -- 27. Biomarkers in cardio-renal dysfunction -- 28. Biomarkers in heart failure with preserved ejection fraction -- Index.
|
520 |
|
|
|a This book presents a comprehensive compendium of case studies to inform clinicians how to optimally deploy the major clinically utilized biomarkers in cardiology. Biomarkers now play an integral role in the treatment and management of patients with congestive heart failure and acute ischemic heart disease because they provide crucial information about the status of individual patients. For that reason, it is important for clinicians to understand the basis for the use of these markers. Every reader may not have the laboratory and/or clinical expertise to understand all the details associated with the use of these markers, which is why this book takes a case oriented approach and by doing so provides a practical resource to guide the clinician through the options available. Cardiac Biomarkers discusses how to use these biomarkers optimally and, in particular, how to understand when values provide actionable information. The book an essential guide for all physicians and healthcare practitioners in the field of cardiology.
|
590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
650 |
|
0 |
|a Heart
|x Diseases
|x Diagnosis.
|
650 |
|
0 |
|a Biochemical markers.
|
650 |
|
0 |
|a Coronary heart disease.
|
650 |
|
0 |
|a Heart failure.
|
650 |
1 |
2 |
|a Biomarkers
|
650 |
1 |
2 |
|a Myocardial Ischemia
|
650 |
2 |
2 |
|a Heart Failure
|
650 |
2 |
2 |
|a Natriuretic Peptides
|x therapeutic use
|
650 |
2 |
2 |
|a Troponin
|x therapeutic use
|
650 |
|
6 |
|a Cœur
|x Maladies
|x Diagnostic.
|
650 |
|
6 |
|a Marqueurs biologiques.
|
650 |
|
6 |
|a Ischémie myocardique.
|
650 |
|
6 |
|a Insuffisance cardiaque.
|
650 |
|
7 |
|a Cardiovascular medicine.
|2 bicssc
|
650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x General.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Diseases.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Evidence-Based Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Internal Medicine.
|2 bisacsh
|
650 |
|
7 |
|a Heart failure
|2 fast
|
650 |
|
7 |
|a Coronary heart disease
|2 fast
|
650 |
|
7 |
|a Biochemical markers
|2 fast
|
650 |
|
7 |
|a Heart
|x Diseases
|x Diagnosis
|2 fast
|
655 |
|
4 |
|a Internet Resources.
|
700 |
1 |
|
|a Maisel, Alan S.,
|e editor.
|
700 |
1 |
|
|a Jaffe, Allan S.,
|e editor.
|
758 |
|
|
|i has work:
|a Cardiac biomarkers (Text)
|1 https://id.oclc.org/worldcat/entity/E39PCFKqhkvB6k9t7xTbVbFK7d
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
773 |
0 |
|
|t Springer eBooks
|
776 |
0 |
8 |
|i Printed edition:
|z 9783319429809
|
830 |
|
0 |
|a 2016 Springer EBA Collection.
|
856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=4723621
|z Texto completo
|
938 |
|
|
|a Askews and Holts Library Services
|b ASKH
|n AH32381837
|
938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL4723621
|
938 |
|
|
|a EBSCOhost
|b EBSC
|n 1260890
|
938 |
|
|
|a ProQuest MyiLibrary Digital eBook Collection
|b IDEB
|n cis36854610
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 13235177
|
994 |
|
|
|a 92
|b IZTAP
|